In this article , on MT Dialog, Dr. Daniel Wallerstorfer, founder and CEO of Novogenia, explains the importance of preventive genetics and pharmacogenetics. While clinical genetics often operates reactively, preventive genetics aims to identify individual health risks early and prevent diseases. Wallerstorfer emphasizes the growing significance of pharmacogenetics, which helps avoid medication side effects through genetic analyses. In this context, Novogenia offers preventive and lifestyle genetic analyses to develop personalized health strategies.